Prophylaxia
Researches salmon signalling substances such as SNAP as a sea lice alternative for salmon farming
Highlights
- New on EvolcAdded 2026-10-30
About Prophylaxia
Prophylaxia researches the use of salmon's natural signalling substances as an alternative to sea lice control. Its work includes different methods of delivering SNAP (Salmon Nest Appeasing Pheromone), which the company describes as an effective and environmentally friendly agent that makes salmon more robust without handling the fish. It also develops new treatment methods and technologies.
The company describes itself as a start-up with roots in the aquaculture and pharmaceutical industries.
Prophylaxia was founded in 2009 and is headquartered in Vikebukt, Norway. It runs a research farm at Daugstad in Vestnes municipality, where its 18 employees carry out the operation. The company offers apprenticeship places and accepts open applications; it had no open positions listed at the time of review.
Product: SNAP (Salmon Nest Appeasing Pheromone) signalling-substance treatments against sea lice in farmed salmon, under research.
Jobs at Prophylaxia
More biotech & pharma companies
Quantidoc
Immune barrier health monitoring for fish farms and hatcheries using its VERIBARR™ analyses of gills, skin and gutNew on EvolcRegenics
Develops marine-derived wound care products for treating burns and chronic woundsNew on EvolcThor Medical
Produces thorium-derived alpha-particle emitters for makers of radioligand cancer therapies and research usersNew on EvolcTribune Therapeutics
Preclinical biopharma developing anti-fibrotic medicines that target CCN signaling, for patients with fibrotic diseaseNew on EvolcVitas
Contract analytical lab in Oslo running DBS biomarker analysis and GMP pharma quality testing for drug, food and research clientsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Squarespace